Fluoxetine for down syndrome

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 14 Jul 2022: Trial registered, NCT05458479
  2. 5 Dec 2022: Trial started, NCT05458479

The trials

NCT05458479: Fluoxetine Treatment of Depression in Down Syndrome

State
Completed
Phase
Phase 4
People
4 taking part
Started
5 Dec 2022
Primary completion
26 Feb 2024
Arms
Fluoxetine
Results
Posted on the registry
  1. 14 Jul 2022: Trial registered
  2. 5 Dec 2022: Trial started
  3. 26 Feb 2024: Trial completed
  4. 30 Mar 2025: Trial results posted

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Also known as Antidepressant medication (fluoxetine), Fluoxetine 20 MG, fluoxetine (Prozac).

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.